Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Study acronym: ESG
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 2 → 5 locations
    • Eligibility criteria expanded, about 43 words
  2. Study sites: 1 to 2v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 1, 2025 to Nov 14, 2025
    v3
  4. Study title shortened, about 16 wordsv2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.
Trial Details
NCT Number NCT07090005
Lead Sponsor Nitinotes Surgical Ltd.
Conditions
(from sponsor)		 Obesity, Overweight
Related terms Obesity, Overweight
Enrollment 184 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov